Shilpa Medicare receives US approval for Varenicline Tablets, 0.5 mg and 1 mg
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
The stethoscope features high acoustic sensitivity and active noise cancellation, minimizing ambient interference to improve auscultation clarity, particularly in noisy hospital settings
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Alkem Medtech to acquire 100% stake of Bombay Ortho
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Subscribe To Our Newsletter & Stay Updated